This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Shortly after isoprenalin infusion was initiated, there were short runs of ventricular tachycardia. Isoprenalin was discontinued, and a temporary transveous pacemaker was implanted. The patient stabilized following pacemaker placement. The following ECG was recorded during one of these episodes of VT.
Ivabradine is an anti-arrhythmic agent that reduces the heart rate through inhibition of the pacemaker current of the sinoatrial node. It has been used to treat both inappropriate sinus tachycardia and sinus tachycardia related to heart failure in children and adults.
Methods We performed a retrospective clinical data review of all consecutive pediatric patients (aged 2–18 years) who underwent orthotopic HT for advanced heart failure at our institution between January 2007 and January 2023. Three patients developed symptomatic sinus node dysfunction at 18, 25, and 38 days and received permanent pacemakers.
so it must be a pediatric ECG. The ECG was done because the heart rate was 230 and the differential included SVT vs. sinus tachycardia. This is typical of pediatric ECGs because the fetal circulation depends on the right ventricle. What can you say about this ECG at a rate of 230 beats per minute?
Objective Describe the methodology and role of CNA for treatment of pediatric patients with functional AVB or SP. with one documented SP after termination of atrial tachycardia at the 3-month follow-up. Methods This is a single-center, case series study. Post-CNA, the median longest pause was 1.3 s s (range 0.8–2.2)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content